We are live on ! Find out more
DFTX

Definium Therapeutics
DFTX

157 hedge funds and large institutions have $282M invested in Definium Therapeutics in 2024 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 51 increasing their positions, 29 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

79% more call options, than puts

Call options by funds: $4.76M | Put options by funds: $2.67M

76% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 29

38% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 21

4% more funds holding

Funds holding: 151 → 157 (+6)

3.03% more ownership

Funds ownership: 57.79% → 60.82% (+3%)

6% less capital invested

Capital invested by funds: $299M → $282M (-$17.7M)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
157
Holders Change
+6
Holders Change %
+3.97%
% of All Funds
2.25%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
29
Increased
51
Reduced
29
Closed
21
Calls
$4.76M
Puts
$2.67M
Net Calls
+$2.1M
Net Calls Change
-$8.54M

Top Buyers

Rank Fund Capital Flow
1
Blackstone Inc
Blackstone Inc
New York
+$14M
2
DCM
Driehaus Capital Management
Illinois
+$9.43M
3
TLP
Tri Locum Partners
New York
+$8.91M
4
DTC
Deep Track Capital
Connecticut
+$6.69M
5
OCA
Octagon Capital Advisors
New York
+$6.02M

Top Sellers

Rank Fund Capital Flow
1
AG
Artal Group
Luxembourg
-$7.27M
2
Two Sigma Investments
Two Sigma Investments
New York
-$2.81M
3
ABG
Ally Bridge Group
New York
-$1.23M
4
IC
Ikarian Capital
Texas
-$696K
5
AGM
Alpine Global Management
New York
-$492K
Name Holding Trade Value Shares
Change 		Change in
Stake
Swiss National Bank
26
Swiss National Bank
Switzerland
$682K +$62.6K +9,000 +8%
MSAM
27
Moloney Securities Asset Management
Missouri
$657K -$138K -19,800 -15%
AI
28
AdvisorShares Investments
Maryland
$621K -$104K -15,000 -12%
DCI
29
Data Collective IV
California
$571K – – –
RhumbLine Advisers
30
RhumbLine Advisers
Massachusetts
$545K +$11.9K +1,711 +2%
Citigroup
31
Citigroup
New York
$481K +$408K +58,591 +226%
Squarepoint
32
Squarepoint
New York
$456K +$557K +80,121 New
Millennium Management
33
Millennium Management
New York
$451K +$551K +79,210 New
AllianceBernstein
34
AllianceBernstein
Tennessee
$429K – – –
UBS AM
35
UBS AM
Illinois
$400K -$53.7K -7,726 -10%
Alyeska Investment Group
36
Alyeska Investment Group
Illinois
$379K +$464K +66,694 New
IC
37
Ikarian Capital
Texas
$356K -$696K -100,000 -62%
XT
38
XTX Topco
Cayman Islands
$337K +$412K +59,222 New
California State Teachers Retirement System (CalSTRS)
39
California State Teachers Retirement System (CalSTRS)
California
$333K +$15.2K +2,184 +4%
Legal & General Group
40
Legal & General Group
United Kingdom
$328K +$30.9K +4,442 +8%
Royal Bank of Canada
41
Royal Bank of Canada
Ontario, Canada
$323K -$71K -10,210 -15%
SC
42
Scotia Capital
Ontario, Canada
$307K – – –
OC
43
Oppenheimer & Co
New York
$298K +$364K +52,381 New
KPWS
44
Kestra Private Wealth Services
Texas
$292K – – –
LPL Financial
45
LPL Financial
California
$273K +$11.3K +1,630 +4%
Deutsche Bank
46
Deutsche Bank
Germany
$267K +$70.9K +10,189 +28%
Citadel Advisors
47
Citadel Advisors
Florida
$244K +$176K +25,263 +144%
MIM
48
MetLife Investment Management
New Jersey
$242K +$296K +42,549 New
Mirae Asset Global ETFs Holdings
49
Mirae Asset Global ETFs Holdings
Hong Kong
$225K +$275K +39,508 New
CF
50
Corebridge Financial
Texas
$219K -$1.66K -238 -0.6%
1
2
3 4 5

DFTX Hedge Fund Activity: Q3 2024 in Review

157 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q3 2024, worth a combined $282M — down 5.9% from $299M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new DFTX positions and 21 closed out — a net gain of 8 holders — while 51 added to existing stakes and 29 trimmed.

The largest buyer was Blackstone Inc, adding an estimated $14M. The largest seller was Artal Group, exiting entirely with an estimated $7.27M sold.

  • 157 institutional investors held Definium Therapeutics (DFTX) as of Q3 2024, up from 151 in Q2 2024.
  • Funds reported $282M of Definium Therapeutics stock for Q3 2024, down 5.9% quarter-over-quarter.
  • 29 funds opened new Definium Therapeutics positions in Q3 2024 and 21 closed out, a net change of +8 holders.
  • The largest Definium Therapeutics buyer in Q3 2024 was Blackstone Inc, an estimated $14M added.
  • The largest Definium Therapeutics seller in Q3 2024 was Artal Group, an estimated $7.27M sold.

Based on aggregated 13F filings for Q3 2024.